Prasugrel, sold under the brand names Effient and Efient, is a medication used to prevent formation of blood clots. It is a platelet inhibitor and an...
21 KB (2,024 words) - 15:12, 7 September 2024
adverse effects it is not much used today. Ticlopidine, clopidogrel and prasugrel (Efient) are all thienopyridines that cause irreversible inhibition of...
46 KB (5,282 words) - 08:16, 30 March 2024
Ticagrelor (section With prasugrel)
revascularisation (restoration of blood flow). Like the thienopyridines prasugrel, clopidogrel and ticlopidine, ticagrelor blocks adenosine diphosphate...
33 KB (3,121 words) - 08:30, 1 July 2024
functions and microglial neuroprotection. The drugs clopidogrel (Plavix), prasugrel (Efient, Effient), ticagrelor (Brilinta), and cangrelor (Kengreal) bind...
10 KB (992 words) - 18:32, 10 December 2023
thrombosis and strokes. Drugs in this class include: clopidogrel (Plavix), prasugrel (Effient), and ticlopidine (Ticlid). Tinoridine was actually a predecessor...
2 KB (233 words) - 01:13, 30 May 2023
combination of aspirin plus an ADP/P2Y inhibitor (such as clopidogrel, prasugrel, ticagrelor, or another) is used to obtain greater effectiveness than...
18 KB (1,752 words) - 10:58, 11 August 2024
esomeprazole, but pantoprazole appears to be safe. The newer antiplatelet agent prasugrel has minimal interaction with (es)omeprazole, hence might be a better antiplatelet...
44 KB (3,709 words) - 08:54, 8 September 2024
Vanflyta (quizartinib) Zelboraf (vemurafenib) Cardiovascular Effient (prasugrel) (co-marketed with Eli Lilly and Company; also sold as Efient) Lixiana/Savaysa...
28 KB (2,326 words) - 02:38, 5 September 2024
bioactivation of the antithrombotic prodrugs ticlopidine, clopidogrel, and prasugrel. As posited in a "Thioester World", thioesters are possible precursors...
13 KB (1,388 words) - 20:22, 15 September 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
32 KB (3,346 words) - 08:35, 21 September 2024
myocardial infarction by at least 50%. P2Y12 inhibitors such as clopidogrel, prasugrel and ticagrelor are given concurrently, also as a loading dose, with the...
130 KB (13,860 words) - 16:04, 17 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
20 KB (2,024 words) - 01:44, 5 October 2024
include aspirin, dipyridamole, ticlopidine, clopidogrel, ticagrelor and prasugrel; the parenteral glycoprotein IIb/IIIa inhibitors are used during angioplasty...
64 KB (6,553 words) - 13:35, 26 September 2024
Sunitinib Platelet aggregation inhibitors (ticlopidine, clopidogrel, and prasugrel) Immunosuppressants (ciclosporin, mitomycin, tacrolimus/FK506, interferon-α)...
49 KB (5,038 words) - 20:12, 15 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
24 KB (2,124 words) - 10:05, 18 August 2024
D; Rosi; Debernardi; Bertho; Mansuy (2012). "Metabolic Activation of Prasugrel: Nature of the Two Competitive Pathways Resulting in the Opening of Its...
23 KB (2,258 words) - 11:33, 16 February 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
29 KB (2,943 words) - 09:59, 9 August 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
31 KB (2,798 words) - 03:28, 18 October 2024
Tirofiban B01AC18 Triflusal B01AC19 Beraprost B01AC21 Treprostinil B01AC22 Prasugrel B01AC23 Cilostazol B01AC24 Ticagrelor B01AC25 Cangrelor B01AC26 Vorapaxar...
3 KB (346 words) - 19:19, 12 March 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
10 KB (906 words) - 09:52, 9 August 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
32 KB (3,305 words) - 17:40, 3 September 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
36 KB (3,334 words) - 03:09, 18 October 2024
aspirin is combined with an ADP receptor inhibitor, such as clopidogrel, prasugrel, or ticagrelor to prevent blood clots. This is called dual antiplatelet...
155 KB (16,694 words) - 04:21, 18 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
97 KB (10,570 words) - 00:30, 17 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
250 KB (25,995 words) - 20:42, 13 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
20 KB (1,790 words) - 13:48, 30 September 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
38 KB (4,040 words) - 22:00, 12 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
53 KB (5,299 words) - 04:25, 14 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
202 KB (20,190 words) - 01:39, 13 October 2024
Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500 MRS-2578 NF-157 NF-340 PIT PPADS Prasugrel PSB-0739 RB-2 Regrelor Suramin Ticagrelor Ticlopidine UDP...
6 KB (509 words) - 19:39, 27 August 2024